OCUGEN INC. DL-,001OCUGEN INC. DL-,001OCUGEN INC. DL-,001

OCUGEN INC. DL-,001

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪261.13 M‬EUR
−0.1565EUR
‪−57.15 M‬EUR
‪5.47 M‬EUR
‪283.71 M‬
Beta (1Y)
1.68

About Ocugen, Inc.


CEO
Shankar Musunuri
Headquarters
Malvern
Website
Founded
2013
FIGI
BBG007PQLLW4
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange OCUGEN INC. DL-,001 stocks are traded under the ticker 2H51.
We've gathered analysts' opinions on OCUGEN INC. DL-,001 future price: according to them, 2H51 price has a max estimate of 7.41 EUR and a min estimate of 3.70 EUR. Watch 2H51 chart and read a more detailed OCUGEN INC. DL-,001 stock forecast: see what analysts think of OCUGEN INC. DL-,001 and suggest that you do with its stocks.
2H51 reached its all-time high on Nov 3, 2021 with the price of 15.8750 EUR, and its all-time low was 0.1620 EUR and was reached on Jul 14, 2020. View more price dynamics on 2H51 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track OCUGEN INC. DL-,001 financials in yearly and quarterly reports right on TradingView.
OCUGEN INC. DL-,001 is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
2H51 earnings for the last quarter are −0.04 EUR per share, whereas the estimation was −0.05 EUR resulting in a 9.09% surprise. The estimated earnings for the next quarter are −0.05 EUR per share. See more details about OCUGEN INC. DL-,001 earnings.
OCUGEN INC. DL-,001 revenue for the last quarter amounts to ‪1.02 M‬ EUR, despite the estimated figure of ‪359.26 K‬ EUR. In the next quarter, revenue is expected to reach ‪379.88 K‬ EUR.
2H51 net income for the last quarter is ‪−11.65 M‬ EUR, while the quarter before that showed ‪−14.27 M‬ EUR of net income which accounts for 18.34% change. Track more OCUGEN INC. DL-,001 financial stats to get the full picture.
No, 2H51 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 15, 2024, the company has 65.00 employees. See our rating of the largest employees — is OCUGEN INC. DL-,001 on this list?
Like other stocks, 2H51 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OCUGEN INC. DL-,001 stock right from TradingView charts — choose your broker and connect to your account.